Skip to main content

Protheragen-ING Offers a Full Range of Nonsteroidal Anti-inflammatory APIs, Including Celecoxib and Crisaborole

In the world of pharmaceutical ingredients, quality and efficacy have never been more important. To address this need, Protheragen-ING continues to prove itself as a top supplier of nonsteroidal anti-inflammatory APIs (NSAIDs), a class of anti-inflammatory APIs. These widely used compounds are helpful in managing various inflammatory conditions such as arthritis, musculoskeletal injuries, toothaches, menstrual pain, and headaches.

Protheragen-ING, an ISO9001 certified supplier of pharmaceutical ingredients and specialty chemicals, provides a full range of NSAID APIs. With its strict quality control and manufacturing process, the certification further solidifies its position as a reliable partner in pharmaceutical solutions.

One of Protheragen-ING’s top products is celecoxib (CAS 169590-42-5). Known in the market as Celebrex and Celebra, celecoxib is a cyclooxygenase-2 (COX-2) inhibitor. Its selective inhibition mechanism reduces gastrointestinal bleed risk commonly associated with other NSAIDs. Celecoxib is used to manage symptoms of various arthritis forms and also for familial adenomatous polyposis (FAP) to prevent precancerous polyps in the colon. With EP/USP/JP standard, Protheragen-ING’s celecoxib meets global pharmacopoeia standards.

Along with celecoxib, crisaborole (CAS 906673-24-3) is another key product in Protheragen-ING’s portfolio. Known as 4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile, crisaborole is a topical treatment for inflammatory skin conditions like eczema. Its molecular structure with boron ester offers a new approach in anti-inflammatory APIs. Protheragen-ING ensures their crisaborole meets in-house standards, which shows the company’s commitment to match its pharmaceutical products with scientific and market needs. The company approaches API production in multiple ways, synthesizing ingredients that meet Good Manufacturing Practice (GMP) standards. Protheragen-ING offers flexibility and innovation with custom purification, API synthesis, and stability testing so potential pharmaceutical partners can have solutions tailored to their product requirements.

Meanwhile, a large number of other NSAID APIs are also available at Protheragen-ING, for instance, Etoricoxib (CAS 202409-33-4), Piroxicam (CAS 36322-90-4), Sulindac (CAS 38194-50-2), Imrecoxib (CAS 395683-14-4), Etodolie acid (CAS 41340-25-4), Flurbiprofen (CAS 5104-49-4), Pranoprofen (CAS 52549-17-4), and more.

The certified quality management systems support Protheragen-ING’s manufacturing process, ensuring product quality, safety, and reliability. As the industry evolves with innovation and compliance, Protheragen-ING’s full range of APIs and their benefits is a forward thinking, customer centric approach to pharmaceutical manufacturing.

Please visit the website to learn more.

About Protheragen-ING

Protheragen-ING upholds its quality and reliability as an ISO9001 certified supplier and also contributes to the landscape of anti-inflammatory treatments with new products like Celecoxib and Crisaborole. Through continuous investment in technology and adherence to strict quality standards, Protheragen-ING is a symbol of excellence and trust in the pharmaceutical industry.

Media Contact

Name
Protheragen-ING
Contact name
Amy George
State
New York
Country
United States
Url
https://www.protheragen-ing.com/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.